Montreal researchers who are studying how ovarian cancer cells can reawaken after going dormant are ultimately trying to ...

Ovarian cancer is the deadliest form of gynecologic cancer, taking the lives of more than 13,000 women in the U.S. each year.

Researchers have discovered the likely origin of a deadly form of ovarian cancer, offering new hope for early detection and ...

Medically reviewed by Renita White, MD Cancer that develops in the ovaries (the egg-producing reproductive organs) is ...

More people with ovarian cancer are surviving longer after diagnosis in Somerset then almost anywhere else in the country, a ...

AbbVie’s Elahere (mirvetuximab soravtansine-gynx) has demonstrated consistent survival benefits in a subset of ovarian cancer ...

Toon Van Gorp, MD, PhD, discussed findings from the MIRASOL trial and the potential of mirvetuximab to redefine treatment ...

AbbVie has pointed to a very strong launch trajectory for Elahere, with sales rocketing to $480 million last year, almost ...

Adding afuresertib to paclitaxel did not improve outcomes in patients with platinum-resistant ovarian cancer in a phase 2 trial.

Optimizing telehealth during public health emergencies to minimize in-person appointments puts less burden on patients and ...

Ovarian cancer affects anyone with ovaries, most commonly women who are older than 50, the NHS explains - here are the ...

An ovarian cancer campaigner, fundraiser and survivor from Norfolk who has taken her story to parliament, is raising awareness of ovarian cancer and the importance of getting checked if something ...